Bruker (BRKRP) Share-based Compensation Growth (5y) (2015 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | - | - | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 49.85% |
| Sep 30, 2024 | 10.25% |
| Jun 30, 2024 | 14.42% |
| Mar 31, 2024 | 11.32% |
| Dec 31, 2023 | -28.00% |
| Sep 30, 2023 | 7.78% |
| Jun 30, 2023 | 12.89% |
| Mar 31, 2023 | 21.06% |
| Dec 31, 2022 | 12.57% |
| Sep 30, 2022 | 4.70% |
| Jun 30, 2022 | 7.07% |
| Mar 31, 2022 | 7.89% |
| Dec 31, 2021 | 19.74% |
| Sep 30, 2021 | 8.73% |
| Jun 30, 2021 | 11.38% |
| Mar 31, 2021 | 9.10% |
| Dec 31, 2020 | 1.76% |
| Sep 30, 2020 | 13.26% |
| Jun 30, 2020 | 14.87% |
| Mar 31, 2020 | 8.45% |
| Dec 31, 2019 | -17.11% |
| Sep 30, 2019 | 10.76% |
| Jun 30, 2019 | -2.82% |
| Mar 31, 2019 | 9.16% |
| Dec 31, 2018 | 11.49% |
| Sep 30, 2018 | 15.58% |
| Jun 30, 2018 | 11.38% |
| Mar 31, 2018 | 6.79% |
| Dec 31, 2017 | 6.47% |
| Sep 30, 2017 | 8.10% |
| Jun 30, 2017 | 7.28% |
| Mar 31, 2017 | 6.47% |
| Dec 31, 2016 | 4.36% |
| Sep 30, 2016 | 4.56% |
| Jun 30, 2016 | 3.13% |
| Mar 31, 2016 | 4.10% |
| Dec 31, 2015 | 2.98% |
| Sep 30, 2015 | 5.29% |
| Jun 30, 2015 | -3.81% |
| Mar 31, 2015 | 6.58% |